BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8175306)

  • 1. Modulation of the expression of the granulocyte adhesion molecule, CR3, by percutaneous transluminal coronary angioplasty and contrast media.
    Feldman LJ; Chollet-Martin S; Himbert D; Juliard J; Pasquier C; Elbim C; Steg PG
    Invest Radiol; 1994 Mar; 29(3):313-8. PubMed ID: 8175306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty.
    Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Takabatake Y
    J Am Coll Cardiol; 1996 Nov; 28(5):1127-33. PubMed ID: 8890805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil activation after percutaneous transluminal coronary angioplasty.
    Ikeda H; Nakayama H; Oda T; Kuwano K; Yamaga A; Ueno T; Yoh M; Hiyamuta K; Koga Y; Toshima H
    Am Heart J; 1994 Dec; 128(6 Pt 1):1091-8. PubMed ID: 7527181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty.
    Mickelson JK; Ali MN; Kleiman NS; Lakkis NM; Chow TW; Hughes BJ; Smith CW
    J Am Coll Cardiol; 1999 Jan; 33(1):97-106. PubMed ID: 9935015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
    Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
    Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of coronary artery disease in patients receiving percutaneous transluminal coronary angioplasty: angiographic comparison of angioplasty and non-angioplasty sites.
    Ohtani R; Hiasa Y
    Intern Med; 1995 Jul; 34(7):611-7. PubMed ID: 7496068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils.
    Neuman E; Huleatt JW; Jack RM
    J Immunol; 1990 Nov; 145(10):3325-32. PubMed ID: 1977799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concept of maximal flow ratio for immediate evaluation of percutaneous transluminal coronary angioplasty result by videodensitometry.
    Pijls NH; Aengevaeren WR; Uijen GJ; Hoevelaken A; Pijnenburg T; van Leeuwen K; van der Werf T
    Circulation; 1991 Mar; 83(3):854-65. PubMed ID: 1999036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Heart; 2000 Jul; 84(1):83-7. PubMed ID: 10862597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin E supplementation on circulating cell adhesion molecules pre- and post-coronary angioplasty.
    Ferns GA; Forster LA; Williams JC; Tull SP; Verma PK; Starkey B; Gershlick AH
    Ann Clin Biochem; 2000 Sep; 37 ( Pt 5)():649-54. PubMed ID: 11026517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty.
    Hokimoto S; Ogawa H; Saito T; Oshima S; Noda K; Soejima H; Takazoe K; Date H; Ishibashi F; Nakamura S; Yasue H
    Jpn Circ J; 2000 Nov; 64(11):831-4. PubMed ID: 11110426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty.
    Tsutsui M; Shimokawa H; Tanaka S; Yoshihara S; Higuchi S; Matsuguchi T; Okamatsu S
    Jpn Circ J; 1996 Jan; 60(1):27-34. PubMed ID: 8648881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?
    Mickelson JK; Lakkis NM; Villarreal-Levy G; Hughes BJ; Smith CW
    J Am Coll Cardiol; 1996 Aug; 28(2):345-53. PubMed ID: 8800108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty.
    Neumann FJ; Ott I; Gawaz M; Puchner G; Schömig A
    J Am Coll Cardiol; 1996 Mar; 27(4):819-24. PubMed ID: 8613609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
    Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty.
    Serrano CV; Ramires JA; Venturinelli M; Arie S; D'Amico E; Zweier JL; Pileggi F; da Luz PL
    J Am Coll Cardiol; 1997 May; 29(6):1276-83. PubMed ID: 9137224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between angiographic success and functional improvement assessed by exercise test following percutaneous transluminal coronary angioplasty.
    BarillĂ  F; Romeo F; Tomai F; Pace V; Valente A; Martuscelli E; Nigri A; Reale A
    Panminerva Med; 1991; 33(3):140-4. PubMed ID: 1771098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vasomotion after percutaneous transluminal coronary angioplasty depends on the severity of the culprit lesion.
    Mandinov L; Kaufmann P; Staub D; Buckingham TA; Amann FW; Hess OM
    J Am Coll Cardiol; 1997 Sep; 30(3):682-8. PubMed ID: 9283526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.